To tell or not to tell: South African women's disclosure of HIV status during pregnancy

Visser, Maretha; Neufeld, Sharon; Villiers, Annelize de; Makin, J.D.; Forsyth, Brian W.C.

doi:10.1080/09540120701842779

Cited by 99 publications

(93 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This finding is in line with researches done in South Africa and northern Nigeria. 12,13 In contrary, it is extremely higher than reports from Uganda, Tanzania and Zimbabwe. 6,14,15 The difference could be due to variations in study population, study design, sampling size.…”

Section: Discussioncontrasting

confidence: 51%

“…This is also true according to other studies. 12 The reason behind this may be that women who belief HIV serostatus disclosure is important share their HIV positive serostatus because they feel responsible both for the health of their sexual partner and their infant. At the same time, they may belief that HIV positive serostatus disclosure creates opportunities to discuss and implement HIV risk reduction strategies with their sexual partner, improves access to necessary medical treatment and care, and increases opportunities for financial and psychosocial support.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

HIV serostatus disclosure and associated factors among HIV positive pregnant women attending antenatal care services in northwest Ethiopia

Alemayehu¹,

Tadesse²,

Adefris³

et al. 2014

Int. j. infect. control

View full text Add to dashboard Cite

Disclosure of HIV serostatus by pregnant women to their sexual partners is critical for the successful prevention of mother to child transmission of HIV. This study examined the magnitude and factors associated with disclosure of HIV serostatus by pregnant women attending antenatal care services to their sexual partners in northwest Ethiopia.Institutional-based cross-sectional study design was employed from June to September 2013. All HIV positive pregnant women attending antenatal care follow up at government health facilities of Gondar, Bahir Dar and Metema town during the data collection period were included in the study. Data were collected by using pretested and structured interview questionnaire. Data analyses were done using SPSS for windows version 17.0. Multivariable analyses were applied to identify the relative effect of explanatory variables on the dependent variable. This study showed that the magnitude of HIV serostatus disclosure by HIV positive pregnant women attending antenatal care services to their sexual partners was high. However, this doesn't mean that there will be no need for further intervention activities as significant proportions of the study population still demonstrates nondisclosure. So, it is crucially important for HIV prevention programs to focus on factors, such as residence, increasing people's awareness about HIV and ensuring smooth communication between sexual partners concerning HIV serostatus to address the problem.

show abstract

Section: Discussioncontrasting

confidence: 51%

Section: Discussionmentioning

confidence: 99%

HIV serostatus disclosure and associated factors among HIV positive pregnant women attending antenatal care services in northwest Ethiopia

Alemayehu¹,

Tadesse²,

Adefris³

et al. 2014

Int. j. infect. control

View full text Add to dashboard Cite

show abstract

“…In fact, among people living with HIV (PLWH) in the Netherlands, one in every five is of African or Caribbean origin (HIV Monitoring Foundation, 2008). Previous research has demonstrated that, because of HIV-related stigma, disclosure of HIV status is an important concern among PLWH of African and Caribbean origin, both in their home countries and among the diaspora (Anderson & Doyal, 2004;Kumar, Waterman, Kumari, & Carter, 2006;Visser, Neufeld, de Villiers, Forsyth, & Makin, 2008).…”

Section: Introductionmentioning

confidence: 99%

HIV status disclosure among HIV-positive African and Afro-Caribbean people in the Netherlands

et al. 2011

View full text Add to dashboard Cite

HIV status disclosure is often characterized as a dilemma. On the one hand, disclosure can promote health, social support, and psychological well-being. On the other, disclosure can lead to stigmatization, rejection, and other negative social interactions. Previous research has shown that HIV status disclosure is a reasoned process whereby the costs and benefits to oneself and to others are weighed. As such, understanding disclosure requires understanding the reasons for and against disclosure employed by people living with HIV (PLWH). In this study, disclosure among a population disproportionately affected by HIV in the Netherlands, namely African and Afro-Caribbean diaspora, was investigated. Reasons for nondisclosure were fear of stigmatization, previous negative experiences with disclosure, having observed the stigmatization of other PLWH, shame, the desire to protect others - particularly one's children and family - from stigmatization by association and/or worrying, and the belief that one's HIV status is a private matter. Participants reported disclosing because they were in a close and supportive relationship, disclosure led to emotional release, disclosure could lead to emotional or financial support, they felt a perceived duty to inform, and they had a desire to educate others about sexual risk-taking. The findings suggest that stigma plays an important role in disclosure decisions among these populations. They further point to a need for HIV-related stigma reduction interventions in African and Afro-Caribbean communities and culturally sensitive counseling for PLWH whereby caregivers do not automatically assume that disclosure is best but rather provide a safe environment in which the costs and benefits of disclosure can be weighed and strategies for disclosure can be developed, if perceived as beneficial by PLWH.

show abstract

“…Positive rewards resulting from disclosure include increased social support and intimacy with partners, and reaffirmation of one's sense of self [39,40]. However, negative consequences include risk of stigma and violence [41][42][43]. Our findings on disclosure are in agreement with the review of 17 studies by Medley et al [44] which also found high rates of non-disclosure and concluded that "barriers to disclosure identified by the women included fear of accusations of infidelity, abandonment, discrimination and violence".…”

Section: Discussionmentioning

confidence: 99%

The impact of highly active antiretroviral therapy on high-risk behaviour of HIV-infected patients in sub-Saharan Africa

Kaye

Kakaire

Osinde

et al. 2013

J Infect Dev Ctries

View full text Add to dashboard Cite

Introduction: High-risk sexual behaviors such as multiple sexual partners, inconsistent condom use, acquisition of sexually transmitted infection (STIs), and non-use of contraceptives persist in HIV patients undergoing care. We conducted a systematic review of studies conducted in the era of increased access to HAART (2000HAART ( -2010 to assess whether wide-scale use of HAART was associated with high-risk behavior among HAART-using patients. Methodology: We conducted a comprehensive search of databases (AIDSLINE, National Library of Medicine, MEDLINE, PubMed, CINHAL and EMBASE) from January 2002 to January 2010, reviewed conference proceedings and journals, and contacted the researchers involved. We analyzed the association of high-risk behaviors (non-disclosure of sero-status to sexual partners, inconsistent condom use, unprotected sexual intercourse, multiple sexual partners, non-use of contraceptives and acquisition of STIs) with using HAART. Information from eligible studies was abstracted using a standardized checklist. Fourteen English-language studies met the selection criteria of having high-risk behavior as an outcome in patients using HAART in sub-Saharan Africa. Results: Of the 92 eligible articles screened, 14 met the criteria for inclusion as primary articles, 10 showed that HAART is not associated with increased high-risk behavior, two showed increase in acquisition of STIs among HAART-using patients, (which was inconsistent with other measures of high-risk behavior), and two studies showed short-term increase in high-risk behavior. Conclusions: Persistence of high-risk behavior in HAART-using patients suggests that more effort needs to be incorporated in HIV care to reduce such behavior to reduce HIV transmission to uninfected populations.

show abstract

To tell or not to tell: South African women's disclosure of HIV status during pregnancy

Cited by 99 publications

References 16 publications

HIV serostatus disclosure and associated factors among HIV positive pregnant women attending antenatal care services in northwest Ethiopia

HIV serostatus disclosure and associated factors among HIV positive pregnant women attending antenatal care services in northwest Ethiopia

HIV status disclosure among HIV-positive African and Afro-Caribbean people in the Netherlands

The impact of highly active antiretroviral therapy on high-risk behaviour of HIV-infected patients in sub-Saharan Africa

Contact Info

Product

Resources

About